News

The PRIDE study is collecting demographic data to help better study underrepresented patient populations.

The importance of increasing healthcare quality and access in rural areas transcends political party lines.

A new survey has revealing findings about public awareness surrounding burnout among healthcare professionals.

Why the introduction of telehealth kiosks in employers is part of a trend of increased patient visibility.

What the new partnership between the pharmacy chain and tech giant means.

How far along are healthcare organizations in their pursuit of value-based care and the Triple Aim?

The number of members joining Health Care Sharing Ministries are swelling. One reason may be that consumers don’t understand such organizations don’t provide actual health insurance.

A women’s health organization is concerned about the safety and effectiveness of bremelanotide (Vyleesi) after FDA approved it to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.

A new report from OptumRx reveals the top 4 drugs in development for the second quarter of 2019.

The elements of workplace leadership that have been forgotten in a digital age.

How hospitals are using savings from the 340B program to support other programs.

Large-scale population health study to provide more abundant data on disease threats, treatments, and outcomes.

The pharmacy chain is offering free testing in partnership with Greater than AIDS

While generally used at a population level, addressing SBDoH factors can and should be personalized to individuals.

With a record number of innovative drugs queued for FDA approval, managed healthcare executives have an eye toward innovative new products that tackle difficult conditions.

With a country-wide focus on reducing the cost of prescription drugs, managed healthcare executives make their forecasts concerning the future of list prices.

How social media is opening new study opportunities.

New study shows that the public thinks about SDOH differently than academics.

The Trump Administration is calling for better price transparency to help control healthcare costs-but is publishing list prices enough?

One study suggests that, after accounting for other factors, MSSPs do not have any impact on outcomes or costs.

Study shows Medicaid expansion could result in more favorable heart health.

How the right benefit design can help increase patient engagement and adherence to key maintenance therapies.

A new study analyzed the effects of telemedicine vs. face-to-face interventions for insomnia.

The first FDA-approved device to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.

The service is designed to help CVS Caremark PBM clients more easily contract, implement, and manage their choice of available and emerging third-party health and wellness benefit solutions.

As healthcare becomes more patient-centric, can healthcare technology keep up?

What the move could mean for patient outcomes.

A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.

Being a CEO can be a fulfilling-yet demanding-role. Here are 12 stress-busters that promote self-care.

Enrollment impacts an MAO’s revenue and profitability and is a key driver to becoming successful. Here are ways to better understand enrollment potential for new organizations.